DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Angiomax (Bivalirudin) - Hypersensitivity - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypersensitivity (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Angiomax (Bivalirudin) where reactions include hypersensitivity. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Angiomax side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08

Patient: 52 year old male, weighing 78.4 kg (172.5 pounds)

Reactions: Hypersensitivity, Respiratory Depression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Adenosine
    Indication: Arterial Therapeutic Procedure
    Start date: 2012-08-01
    End date: 2012-08-01

Angiomax
    Dosage: 12 ml, bolus, intravenous, 28 ml/hr, intravenous
    Indication: Percutaneous Coronary Intervention
    Start date: 2012-08-01
    End date: 2012-08-01

Angiomax
    Dosage: 12 ml, bolus, intravenous, 28 ml/hr, intravenous
    Indication: Percutaneous Coronary Intervention
    Start date: 2012-08-01

Contrast Media
    Start date: 2012-08-01
    End date: 2012-08-01



Possible Angiomax side effects in male

Reported by a physician from United States on 2012-07-31

Patient: male

Reactions: Heart Rate Decreased, Hypersensitivity, Mouth Haemorrhage, Blood Pressure Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Angiomax



Possible Angiomax side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-14

Patient: 82 year old female, weighing 43.5 kg (95.7 pounds)

Reactions: Hypersensitivity, Hypotension, Cardiac Arrest, Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Angiomax
    Dosage: intravenous ; infusion intravenous
    Indication: Percutaneous Coronary Intervention
    Start date: 2011-01-11

Angiomax
    Dosage: intravenous ; infusion intravenous
    Indication: Percutaneous Coronary Intervention
    Start date: 2011-01-11

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017